Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS).

Altschuler, Eric L; Kast, Richard E

Altschuler, Eric L; Kast, Richard E.

Altschuler EL; Department of Physical Medicine and Rehabilitation, Metropolitan Hospital, New York, NY, USA. Electronic address: altschue@nychhc.org.
Kast RE; IIAIGC Study Center, 22 Church Street, Burlington, VT 05401, USA.

Med Hypotheses ; 141: 109774, 2020 08.

Article in English | MEDLINE | ID: covidwho-164397

Subject(s)

Betacoronavirus; Colchicine/therapeutic use; Coronavirus Infections/complications; Dapsone/therapeutic use; Olanzapine/therapeutic use; Pneumonia, Viral/complications; Respiratory Distress Syndrome/drug therapy; Adult; COVID-19; Chemotaxis, Leukocyte/drug effects; Colchicine/administration & dosage; Dapsone/administration & dosage; Humans; Interleukin-8/physiology; Neutrophils/drug effects; Olanzapine/administration & dosage; Pandemics; Respiratory Distress Syndrome/etiology; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Respiratory Distress Syndrome / Colchicine / Coronavirus Infections / Dapsone / Betacoronavirus / Olanzapine Topics: Long Covid Limits: Adult / Humans Language: English Journal: Med Hypotheses Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google